$Successful Use of Apremilast in Treatment of Refractory Hailey Hailey Disease$

Successful Use of Apremilast in Treatment of Refractory Hailey Hailey Disease

Saved in:

Bibliographic Details
Main Authors:	Ramandeep Kaur, Ishan Agrawal, Seema Sood
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-10-01
Series:	Indian Dermatology Online Journal
Online Access:	https://journals.lww.com/10.4103/idoj.idoj_524_23
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

[Artículo traducido] Enfermedad de Hailey-Hailey recalcitrante con respuesta satisfactoria a apremilast
by: M. Mansilla-Polo, et al.
Published: (2024-11-01)

Tofacitinib as a promising treatment for refractory erythroderma-like Hailey–Hailey disease
by: Huaye Bao, et al.
Published: (2025-12-01)

Hailey-Hailey disease successfully treated with naloxone: 2 case reports and Review of the literature on efficacy of opioid receptor antagonist in Hailey-Hailey disease patients
by: Junyou Zheng, et al.
Published: (2025-12-01)

Effective treatment of recalcitrant Hailey-Hailey disease with dupilumab
by: Deep Patel, BS, et al.
Published: (2025-01-01)

Enfermedad de Hailey Hailey
by: Xavier Rueda, et al.
Published: (2019-02-01)

Hailey‐Hailey Disease: A Case Report
by: Romana Riyaz, et al.
Published: (2025-04-01)

Dupilumab, a Potential Novel Treatment for Hailey–Hailey Disease
by: Liliana Gabriela Popa, et al.
Published: (2025-02-01)

Enfermedad de Hailey-Hailey. Tratamiento con dermoabrasión
by: Ernesto Peña Santamaría, et al.
Published: (1994-09-01)

Enfermedad de Hailey-Hailey: presentación clínica infrecuente
by: Jenny Hasbleidy Hurtado, et al.
Published: (2019-08-01)

Hailey‐Hailey Disease: An Updated Review With a Focus on Therapeutic Mechanisms
by: Mahesh Mathur, et al.
Published: (2025-07-01)

Treatment of Hailey-Hailey disease with the Janus kinase inhibitor abrocitinib: A case report
by: Molly Gunyon, et al.
Published: (2025-06-01)

Recalcitrant Hailey-Hailey disease treated with isotretinoin: A family case series
by: Mahesh Mathur, MD, DCP, et al.
Published: (2025-02-01)

Exploring the Risk of Alcohol Addiction and Substance Use Disorders in Darier Disease and Hailey–Hailey Disease
by: William Jebril, et al.
Published: (2025-06-01)

Successful treatment by deucravacitinib of psoriasis refractory to apremilast
by: Shigeki Inui, et al.
Published: (2025-06-01)

Is apremilast a treatment for SAPHO syndrome?
by: Ju Zhang, et al.
Published: (2024-12-01)

Apremilast treatment of immune-mediated inflammatory skin diseases: a narrative review
by: Xiaoqian Liang, et al.
Published: (2025-08-01)

Apremilast Cocrystals with Phenolic Coformers
by: Yelizaveta Naumkina, et al.
Published: (2024-12-01)

Clinical experience with apremilast for psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2018-09-01)

THE EFFICACY AND SAFETY OF THE NEW DRUG APREMILAST FOR THE TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS
by: Yu. L. Korsakova, et al.
Published: (2016-12-01)

Comorbid psoriasis-bipolar disorder successfully treated with apremilast: much more than a mere coincidence?
by: Muhammed Razmi T, et al.
Published: (2020-06-01)

Delayed lichenoid drug eruption associated with apremilast
by: Betty Hinderks-Davis, MD, et al.
Published: (2025-05-01)

Successful Treatment with Intravenous Cyclophosphamide for Refractory Adult-Onset Still’s Disease
by: Yoshika Tsuji, et al.
Published: (2015-01-01)

Successful Treatment of Refractory Inspissated Bile Syndrome Using Gastrografin
by: Justin J. Guan, et al.
Published: (2024-04-01)

Expression dynamics of cytokine genes is related to the apremilast treatment effectiveness in patients with severe psoriasis
by: Dmitry A. Verbenko, et al.
Published: (2024-03-01)

Apremilast Coadministered with Secukinumab for Effective Treatment of Acrodermatitis Continua of Hallopeau: A Case Report
by: Yao XY, et al.
Published: (2025-05-01)

Management of treatment-resistant acquired perforating dermatosis with apremilast: A novel therapeutic approach
by: Humza Zaidi, BS, et al.
Published: (2025-06-01)

Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasisResearch in context
by: Khalaf Kridin, et al.
Published: (2025-01-01)

The efficacy of apremilast in pemphigus: a systematic review of case reports
by: Roudin Hussain Alhasawi, et al.
Published: (2025-05-01)

APREMILAST: AN UPDATE ON ITS EFFICACY AND SAFETY DURING LONG-TERM TREATMENT OF PATIENTS WITH PSORIATIC ARTHRITIS
by: Yu. L. Korsakova, et al.
Published: (2018-11-01)

Evaluating prevalence and consequence of residual disease in individuals with psoriasis receiving apremilast treatment: results from a US patient survey
by: Tina Bhutani, et al.
Published: (2024-12-01)

Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
by: Saurabh Bhatia
Published: (2022-09-01)

Non-FDA-Approved Uses of Apremilast in Dermatology: A Review of Current Available literature
by: Saurabh Bhatia
Published: (2022-09-01)

Successful Treatment of Refractory Generalized Granuloma Annulare with Upadacitinib
by: Alexis Coican, et al.
Published: (2024-01-01)

Lichenoid dysplasia treated by apremilast - report of two cases and review of literature
by: Shiladitya Sil, et al.
Published: (2025-04-01)

Assessing the Effect of Apremilast on Serum Leptin levels in Obese Patients with Psoriasis
by: Haitham Mohammed Saad, et al.
Published: (2024-12-01)

Successful Use of Bortezomib in an Adolescent with Refractory TTP
by: Junaid Ahmad Wali, et al.
Published: (2023-01-01)

Role of Apremilast in Stabilization of Disease Activity in Acquired Dermal Macular Hyperpigmentation (ADMH): A Pilot Study
by: Apoorva Sharma, et al.
Published: (2025-05-01)

Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report
by: Mario Valenti, et al.
Published: (2024-12-01)

The efficacy and safety of apremilast in patients with psoriatic arthritis concurrent with comorbidity in clinical practice
by: E. Yu. Loginova, et al.
Published: (2019-07-01)

Refractory Uveitis in Patient with Castleman Disease Successfully Treated with Tocilizumab
by: Toshiyuki Oshitari, et al.
Published: (2012-01-01)